The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It'll be closer to 0.22 than 0.32 at the bell tomorrow - that RNS is awful, vague and ambiguous.
He may well seem frustrated and even annoyed, but seemingly unable to impact enough to make a positive outcome.
The ongoing absence of a CFO role encouraging lack of discipline on spend and no immediate term revenue means an EGM for headroom is inevitable here.
*Re-signing
That hyphon is crucial !
Couple of delayed bulky (relatively) buys today
Perhaps (in a P&D context) you're part of the problem, not the solution. You are not the messiah, you're a very naughty boy.
You simply talk nonsense, blind optimism, flicking from Q2/Q3/Q4/Q1-Q2 with a nonsenical, wishy thinking list.
"tricky Q2" "Q3 tomorrow" "hopeful for Q4" - you are either naive to the extreme or simply a characture, I can't decide which.
Stinkymalinky
That sounds like wishful thinking and I would be delighted to be proven wrong, but I think the written word generally comes with more certainty than the spoken one.
Some certainty or clarity about what that support is would go a long way, something like "deferring payments", "additional funding" not subjective phrases like "...appreciates the support it continues to receive" - that is not a million miles from the misleading updated, pre-FM, when apparently the revised offtake was "with the lawyers"
It's purely subjective, as with most of the RNS.
I am a holder, I am underwater, I am not a de-ramper, but truly taking that as a positive is tantamount to confirmation bias.
What it basically confirms is the whole relocation/conversion of the RHA mill was a completely pointless exercise, unless of course it was merely a smokescreen by GR and/or GM to appease the natives.
The market doesn't hate it though, so take the win
Not the next RNS but future financial reports (half-year or full-year) should contain details of cash generation
Another day, another disappointment
"Some people believe Premier African Minerals is a matter of life and death, I am very disappointed with that attitude. I can assure you it is much, much more important than that."
George Roach
DavidAsh, of course it's in my opinion, and the language was clearly on that basis.
It still stands though, hope for the best but prepare for the worst, the BoD should be held to account on the basis of end Sept. as that's what they put in and RNS, but the end Dec. date didn't appear by chance
Hope you're not my accountant
Minor point, but November is in actual fact, more than 40 days away
23rds a Saturday
The end of September date from the RNS is the one they should be held to but in reality the end of December is the most likely, so prepare for disappointment
Not really sure what your point or question is. If PREM fail to meet (the now lower commiement) then CANMAX enforce a financial penalty to esentiall reduce the pre-payment, failure in cash can result in rollver or additional (net increase - given newly approved) shares in PREM. Ultimately, continued failure to deliver produce or cash CAN result in equity in legal entity containing the mine in question, given a pre-determined value. Expectancy of additional dilution, for OPEX, is alreay built in to pricing, the key point is, do we generate revenue (by way of SC6 dispatch) by November or not?
We will have "a comprehensive RNS on Monday morning"
Feels like a new target given by Canmax and perhaps we're on last chance saloon with them given GR's language
Yep, George currently performing felatio on our Chinese partners